Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
The original approved version was discontinued in 2008 for commercial reasons, not safety concerns
It binds to the GHRH receptors on pituitary somatotrophs, activating the cyclic adenosine monophosphate (cAMP) pathway to initiate the production and release of growth hormone
While NAD+ IV Therapy delivers this nutrient slowly through an infusion, NAD+ injections offer a shorter visit for clients who want cellular energy and cognitive support without committing to a full drip session
The copper-binding nature of this peptide has generated scientific interest across multiple fields, including investigations of protein expression and biological maintenance mechanisms
